Nour Al-Mozain: Why Stem Cell Collection Parameters Need Adjustment in SCD for Gene Therapy?
Nour Al-Mozain, Hemopathologist, Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn about a recent article by Yvette C Tanhehco et al., published in Blood Advances, adding:
“Stay Steady. Establish the Interface
Why do we need to adjust the standard parameters when collecting stem cells from SCD patients for gene therapy?
- Activated platelets and leukocytes promote aggregation and interface disruption
- Increased blood viscosity causes impaired component separation
- Abnormal RBC morphology leads to altered sedimentation dynamics
SCD blood exhibits elevated viscous resistance and abnormal flow behavior, even outside crisis states which leads to unstable interface and lower collection efficiency.
Performing RBC exchange immediately before collection may transiently reduce cellular activation.
Adjusting machine configuration by:
Increasing packing factor (centrifugal force) to compensate for increased viscosity
Collecting deeper within the buffy coat (accepting higher product Hct) improves CD34 and CE.”
Title: Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease
Authors: Yvette C Tanhehco , Suzanne Thibodeaux , Patricia A Shi , Stella T Chou , Shannon A Kelly , Grace Fortes Monis , Carly Newton , Kamille West-Mitchell , Yan Zheng , Christine Fernandez , Christina Anderson , Kimberly Ching , Victoria Coleman-Cowger , Adrienne Shapiro , John P Manis

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough
-
Oct 20, 2026, 14:39Jan Hartmann: How Hemophilia Care Has Advanced Over the Past Decade
-
Oct 20, 2026, 14:27Amna Jamalallail: SCD and Thalassemia in Jeddah – A Public Health Perspective
-
Oct 20, 2026, 14:14Advancing Thalassaemia and Sickle Cell Care Through Nordic Collaboration – TIF
-
Oct 20, 2026, 14:01Ashkan Forouzani։ Warfarin or DOACs in Protein C and S Deficiency?
-
Oct 20, 2026, 13:20The Global Blood Crisis – Are We Solving the Wrong Problem?
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population